Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 119


Immunosuppression via Tenascin-C.

Bellone M, Caputo S, Jachetti E.

Oncoscience. 2015 Aug 21;2(8):667-8. eCollection 2015. No abstract available.


Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential.

Cava C, Bertoli G, Castiglioni I.

BMC Syst Biol. 2015 Sep 21;9(1):62. doi: 10.1186/s12918-015-0211-x.


Targeting Breast Cancer Metastasis.

Jin X, Mu P.

Breast Cancer (Auckl). 2015 Sep 1;9(Suppl 1):23-34. doi: 10.4137/BCBCR.S25460. eCollection 2015. Review.


Metastatic Competence Can Emerge with Selection of Preexisting Oncogenic Alleles without a Need of New Mutations.

Jacob LS, Vanharanta S, Obenauf AC, Pirun M, Viale A, Socci ND, Massagué J.

Cancer Res. 2015 Sep 15;75(18):3713-9. doi: 10.1158/0008-5472.CAN-15-0562. Epub 2015 Jul 24.


MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics.

Di Benedetto M, Toullec A, Buteau-Lozano H, Abdelkarim M, Vacher S, Velasco G, Christofari M, Pocard M, Bieche I, Perrot-Applanat M.

Br J Cancer. 2015 Sep 1;113(5):773-85. doi: 10.1038/bjc.2015.267. Epub 2015 Jul 21.


RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.

Uren PJ, Vo DT, de Araujo PR, Pötschke R, Burns SC, Bahrami-Samani E, Qiao M, de Sousa Abreu R, Nakaya HI, Correa BR, Kühnöl C, Ule J, Martindale JL, Abdelmohsen K, Gorospe M, Smith AD, Penalva LO.

Mol Cell Biol. 2015 Sep 1;35(17):2965-78. doi: 10.1128/MCB.00410-15. Epub 2015 Jun 22.


Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche.

Pantziarka P.

Ecancermedicalscience. 2015 May 21;9:541. doi: 10.3332/ecancer.2015.541. eCollection 2015.


Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.

Miller BW, Morton JP, Pinese M, Saturno G, Jamieson NB, McGhee E, Timpson P, Leach J, McGarry L, Shanks E, Bailey P, Chang D, Oien K, Karim S, Au A, Steele C, Carter CR, McKay C, Anderson K, Evans TR, Marais R, Springer C, Biankin A, Erler JT, Sansom OJ.

EMBO Mol Med. 2015 Jun 15;7(8):1063-76. doi: 10.15252/emmm.201404827.


Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy.

Sainio A, Järveläinen H.

Mol Cell Ther. 2014 May 2;2:14. doi: 10.1186/2052-8426-2-14. eCollection 2014. Review.


Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.

Trembley JH, Unger GM, Gomez OC, Abedin J, Korman VL, Vogel RI, Niehans G, Kren BT, Ahmed K.

Mol Cell Pharmacol. 2014;6(2):15-25.


Neural stem and progenitor cell fate transition requires regulation of Musashi1 function.

MacNicol AM, Hardy LL, Spencer HJ, MacNicol MC.

BMC Dev Biol. 2015 Mar 18;15:15. doi: 10.1186/s12861-015-0064-y.


Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.

Kren BT, Unger GM, Abedin MJ, Vogel RI, Henzler CM, Ahmed K, Trembley JH.

Breast Cancer Res. 2015;17:19. doi: 10.1186/s13058-015-0524-0. Epub 2015 Feb 11.


Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.

Sharif GM, Schmidt MO, Yi C, Hu Z, Haddad BR, Glasgow E, Riegel AT, Wellstein A.

Oncogene. 2015 Mar 16. doi: 10.1038/onc.2015.44. [Epub ahead of print]


The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Plaks V, Kong N, Werb Z.

Cell Stem Cell. 2015 Mar 5;16(3):225-38. doi: 10.1016/j.stem.2015.02.015. Review.


Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network.

Zhu J, Xiong G, Fu H, Evers BM, Zhou BP, Xu R.

Cancer Res. 2015 Apr 15;75(8):1580-91. doi: 10.1158/0008-5472.CAN-14-1027. Epub 2015 Mar 5.


TGF-β1-Induced Epithelial-Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells.

Johansson J, Tabor V, Wikell A, Jalkanen S, Fuxe J.

Front Oncol. 2015 Jan 26;5:3. doi: 10.3389/fonc.2015.00003. eCollection 2015.


Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.

Park SM, Gönen M, Vu L, Minuesa G, Tivnan P, Barlowe TS, Taggart J, Lu Y, Deering RP, Hacohen N, Figueroa ME, Paietta E, Fernandez HF, Tallman MS, Melnick A, Levine R, Leslie C, Lengner CJ, Kharas MG.

J Clin Invest. 2015 Mar 2;125(3):1286-98. doi: 10.1172/JCI78440. Epub 2015 Feb 9.


Spherical cancer models in tumor biology.

Weiswald LB, Bellet D, Dangles-Marie V.

Neoplasia. 2015 Jan;17(1):1-15. doi: 10.1016/j.neo.2014.12.004. Review.


Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer.

Tang YA, Chen CH, Sun HS, Cheng CP, Tseng VS, Hsu HS, Su WC, Lai WW, Wang YC.

Nucleic Acids Res. 2015 Feb 18;43(3):1593-608. doi: 10.1093/nar/gkv024. Epub 2015 Jan 21.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk